Our related work
Accelerated Research has been consolidated into the Emerging Priorities and Consumer-Driven Research initiative under the MRFF 10-year Investment Plan. This initiative supported researchers working to develop new treatments and cures for debilitating conditions, in areas of identified unmet need.
The Australian Brain Cancer Mission is investing $136.66 million to support research into brain cancer. It aims to double the survival rates and improve the quality of life of patients with brain cancer.
The Biomedical Translation Bridge (BTB) is now part of the Medical Research Commercialisation initiative under the MRFF 10-year Investment Plan.
BioMedTech Horizons is now part of the Medical Research Commercialisation initiative under the MRFF 10-year Investment Plan.
This initiative invested $10 million in research to help promote good health practice, prevent disease and keep people out of hospital.
The Cardiovascular Health Mission is investing $220 million. It brings together researchers, health professionals, industry and patients to make transformative improvements in heart and vascular health and stroke for all Australians.
The Clinical Trials Activity initiative will provide $750 million over 10 years from 2022-23. It will help Australian researchers and patients test new treatments through national and international clinical trials.
The Clinician Researchers initiative will provide $200 million over 10 years from 2022-23 to support the next generation of talented Australian researchers. It will support health care professionals researching topics important to clinical care.
The Dementia, Ageing and Aged Care Mission is investing $185 million. It supports older Australians to maintain their health and quality of life as they age, live independently for longer, and access quality care when they need it.
The Early to Mid-Career Researchers initiative will invest $384.2 million over 10 years from 2022-23 in early to mid-career researchers (EMCRs). The initiative will build and grow research capacity and capability in Australia by supporting EMCRs to continue their health and medical research careers.
The Emerging Priorities and Consumer-Driven Research initiative will provide $613 million over 10 years from 2022–23. It will support high-quality research that improves patient care, translates new discoveries into practice, and encourages consumers and researchers to work together.
The Frontier Health and Medical Research initiative will provide $700 million over 10 years from 2022-23 to support researchers to develop new health and medical breakthroughs.
The Genomics Health Futures Mission is investing $500.1 million in genomic research. It will improve testing and diagnosis for many diseases, help personalise treatment options to better target and improve health outcomes. It will also reduce unnecessary interventions and health costs.
The Global Health initiative will provide $30 million over 10 years from 2022–23 to fund projects that improve our understanding of global health threats and how best to tackle them.
The Indigenous Health Research Fund is investing $160 million in Indigenous-led research to tackle health issues facing Aboriginal and Torres Strait Islander people.
The International Clinical Trial Collaboration (ICTC) initiative has been consolidated into the Clinical Trials Activity initiative under the MRFF 10-year Investment Plan. ICTC supported Australian researchers to conduct clinical trial research in collaboration with international researchers.
Keeping Australians out of Hospital has been consolidated into the Preventive and Public Health Research initiative under the MRFF 10-year Investment Plan. This initiative supported research into preventive health measures for chronic health conditions, to keep people out of hospital.
Lifting Clinical Trials and Registries Capacity – Clinical Trials Networks initiative has been consolidated into a part of the Clinical Trials Activity initiative under the MRFF 10-year Investment Plan.
Maternal Health and First 2000 Days/Women’s Health has been consolidated into the Preventive and Public Health Research initiative under the MRFF 10-year Investment Plan.
The Medical Research Commercialisation initiative will provide $450 million over 10 years from 2022-23 to support innovative early stage health and medical research in Australia. It will help researchers transform ideas into life-saving medicines, devices and treatments to help future patients.
The Medical Research Future Fund (MRFF) is a $20 billion long-term investment supporting Australian health and medical research. The MRFF aims to transform health and medical research and innovation to improve lives, build the economy and contribute to health system sustainability.
The Million Minds Mental Health Research Mission is investing $125 million to support a million Australians with mental health issues. This funding will enable access to new approaches to prevention, diagnosis, treatment and recovery.
The Medical Research Future Fund (MRFF) supports Australian health and medical research. Read about some of our projects.
The Australian Government is investing $40 million over 4 years to establish a National Clinical Quality Registry Program.
This initiative will provide $650 million over 10 years from 2022-23 for research infrastructure that will be used to conduct world-class health and medical research.
Date last updated: